Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and Monogram Technologies Inc. recently ...

Zimmer Biomet and Monogram undertake no obligation to update any of these forward-looking statements as the result of new information or to reflect events or circumstances after the date of this ...

Ben Sexson, Monogram Chief Executive Officer, commented, "This FDA 510 (k) clearance is a defining moment for Monogram. It marks the culmination of years of relentless effort, innovation, and ...